Intellectia LogoIntellectia
Product
Resources
Stock
Crypto
Pricing
Sign inTry for Free
Intellectia Logo
Sign in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
Crypto Technical Analysis
AI Screener
Trading Strategy
AI Stock Picker
Swing Trading
Earnings Trading
Stock Chart Patterns

Resources

Learn
Blog
Earnings
Tutorial
Company
About Us
Contact
Press
Reward Program
Partner Program
Tools
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
StockCryptoPricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. TBPH
    4. >
  4. Valuation

Valuation

-
stocks logo
TBPH
-
$
0.000
0.000(0.000%)
    OverviewForecastTechnicalOptionsEarningsFinancialsValuationInsiders

Is TBPH Overvalued？

TBPH is now in the zone, suggesting that TBPH current forward PE ratio of -52.00 is considered compare with the five-year average of -54.91.
P/E
EV/EBITDA
P/S
P/B
P/E
bubble
P/E

TBPH Competitors Valuation Multiple

P/E
EV/EBITDA
P/S
P/E

P/E Multiple

Earnings Growth
Market Cap
stocks logo
TBPH.O
Theravance Biopharma Inc
loss
Average P/E:
-82.63%
477.97M
stocks logo
ARCT.O
Arcturus Therapeutics Holdings Inc
loss
Average P/E:
58.21%
434.75M
stocks logo
KROS.O
Keros Therapeutics Inc
loss
Average P/E:
14.61%
473.36M
stocks logo
SAGE.O
SAGE Therapeutics Inc
loss
Average P/E:
-186.73%
464.18M
stocks logo
CMRX.O
Chimerix Inc
loss
Average P/E:
5.76%
760.86M
stocks logo
OMER.O
Omeros Corp
loss
Average P/E:
484.46M

TBPH Revenue Breakdown & PS Ratio Relation

Currency:USD
By Business
By Region
Composition ()
Name
Revenue
Percentage

TBPH FAQs

Is TBPH currently overvalued based on its P/E ratio?

According to the provided data, TBPH's 5-year historical average forward P/E ratio is -54.87. TBPH forward P/E ratio is -52.00, which is categorized as Fair.

What is the significance of the EV/EBITDA ratio for TBPH?

The EV/EBITDA ratio helps assess the company's valuation relative to its earnings before interest, taxes, depreciation, and amortization, providing a clearer picture of its operating performance.

How has TBPH's Price to Sales (PS) ratio evolved?

The PS ratio increased from 6.23 to 7.14, reflecting changes in the company's revenue relative to its market capitalization.

What are the key indicators to watch for TBPH's financial performance?

Key indicators include valuation ratios (P/E, EV/EBITDA, P/FCF), revenue growth, and profitability metrics to assess overall financial health.

TBPH PE Ratio

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalued
5Y Average PE
-54.91
Current PE
-52.00
Overvalued PE
113.97
Undervalued PE
-223.79

TBPH EV/EBITDA Ratio

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalued
5Y Average EV
-87.97
Current EV
0.00
Overvalued EV
281.04
Undervalued EV
-456.97

TBPH P/S Ratio

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalued
5Y Average PS
10.72
Current PS
4.39
Overvalued PS
15.15
Undervalued PS
6.28

TBPH Competitors Valuation Multiple

P/E
EV/EBITDA
P/S
P/E

P/E Multiple

Earnings Growth
Market Cap
stocks logo
TBPH.O
Theravance Biopharma Inc
loss
Average P/E:
-82.63%
477.97M
stocks logo
ARCT.O
Arcturus Therapeutics Holdings Inc
loss
Average P/E:
58.21%
434.75M
stocks logo
KROS.O
Keros Therapeutics Inc
loss
Average P/E:
14.61%
473.36M
stocks logo
SAGE.O
SAGE Therapeutics Inc
loss
Average P/E:
-186.73%
464.18M
stocks logo
CMRX.O
Chimerix Inc
loss
Average P/E:
5.76%
760.86M
stocks logo
OMER.O
Omeros Corp
loss
Average P/E:
484.46M

TBPH Revenue Breakdown & PS Ratio Relation

Currency:USD
By Business
By Region
Composition ()
Name
Revenue
Percentage

Free Financial AI Agent for Investment

Ask any investment related question and get answer instantly

At what price is TBPH undervalued？Is TBPH overvalued compared to its competitors？

TBPH FAQs

Is TBPH currently overvalued based on its P/E ratio?

According to the provided data, TBPH's 5-year historical average forward P/E ratio is -54.87. TBPH forward P/E ratio is -52.00, which is categorized as Fair.

What is the significance of the EV/EBITDA ratio for TBPH?

The EV/EBITDA ratio helps assess the company's valuation relative to its earnings before interest, taxes, depreciation, and amortization, providing a clearer picture of its operating performance.

How has TBPH's Price to Sales (PS) ratio evolved?

The PS ratio increased from 6.23 to 7.14, reflecting changes in the company's revenue relative to its market capitalization.

What are the key indicators to watch for TBPH's financial performance?

Key indicators include valuation ratios (P/E, EV/EBITDA, P/FCF), revenue growth, and profitability metrics to assess overall financial health.

Free Financial AI Agent for Investment

Ask any investment related question and get answer instantly

At what price is TBPH undervalued？Is TBPH overvalued compared to its competitors？
Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerCrypto Technical AnalysisAI Screener
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings Trading
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySitemap
Start for Free